Tier 2 — strong

Safety and effectiveness of topical dry mouth products containing olive oil, betaine, and xylitol in reducing xerostomia for polypharmacy-induced dry mouth

J A Ship, J A McCutcheon, S Spivakovsky, A R Kerr
Journal of oral rehabilitation 2007 34(10):724-732

Bibliography

PubMed
PMID 17824884
DOI
10.1111/j.1365-2842.2006.01718.x
Funding
Funding was not specified in the indexed record or accessible funding metadata.
Competing interests
A competing-interest declaration was not available in the indexed record or accessible disclosure metadata.

Study snapshot

DesignRandomized crossover local-treatment study
ModelHuman participants
Sample40 adults with medication-related dry mouth; 39 completed
InterventionTopical products with olive oil, betaine and xylitol versus usual dry-mouth care
Duration1 week per regimen
EndpointsSalivary flow; Dry-mouth symptoms; Quality of life

What the study showed, in plain terms

Published in 2007, this source examined betaine hcl and topical formulations. Design: Randomized crossover local-treatment study. Sample/model: 40 adults with medication-related dry mouth; 39 completed. The exposure or intervention was Topical products with olive oil, betaine and xylitol versus usual dry-mouth care. Follow-up or treatment period: 1 week per regimen.

The product combination improved salivary flow, dry-mouth complaints and related quality of life.

Short, incompletely masked multi-ingredient study; cannot isolate betaine or infer benefits of oral TMG supplements.

Continue with TMG Data Center

Continue with Betaine Anhydrous vs Betaine HCl: Which Form Is TMG?

Key findings

  • The product combination improved salivary flow, dry-mouth complaints and related quality of life.
  • The recorded outcome domains were Salivary flow; Dry-mouth symptoms; Quality of life.
  • The result applies to the tested exposure: Topical products with olive oil, betaine and xylitol versus usual dry-mouth care; 1 week per regimen.

What this study can and cannot tell us

  • Short, incompletely masked multi-ingredient study; cannot isolate betaine or infer benefits of oral TMG supplements.
  • An individual controlled trial must be interpreted alongside its comparator, sample size, endpoint selection and independent replication. It does not validate a different commercial formulation or a general longevity claim.
  • Source basis: Indexed abstract and bibliographic data. Missing method details, funding information or participant denominators are not inferred.

Related papers in the corpus

Tier 4
Meal-Time Supplementation with Betaine HCl for Functional Hypochlorhydria: What is the Evidence?
Thomas G Guilliams et al. · Integrative medicine (Encinitas, Calif.) · 2020
Tier 2
Gastric reacidification with betaine HCl in healthy volunteers with rabeprazole-induced hypochlorhydria
Marc R Yago et al. · Molecular pharmaceutics · 2013
Tier 2
The use of betaine HCl to enhance dasatinib absorption in healthy volunteers with rabeprazole-induced hypochlorhydria
Marc R Yago et al. · The AAPS journal · 2014
Tier 2
Food, Acid Supplementation and Drug Absorption - a Complicated Gastric Mix: a Randomized Control Trial
Dalga D Surofchy et al. · Pharmaceutical research · 2019

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified

Dr. Khaled Mahmoud, MBBChCritical Care Medicine, Longevity Science & Editorial Direction Dr. Amr Yasser, PhDCardiometabolic, Musculoskeletal, Gut & Bioavailability Dr. Abdulla Mostafa, PhDCellular Senescence, Neurological, Mitochondrial & Brain-Ageing Biology